RecruitingNCT07226895
MT1988 and health measures in young people at risk for psychosis
About this title
Read the official source — NCT07226895Medication studyAges 17–30United StatesSchizophrenia
Understand this study
Who could participate?
Listed age limits: 17 years to 30 years.
- Listed locations
- Irvine and 14 more locationsSee all locations and recruitment
- Study phase
- Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: March 3, 2026
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 150
- Sponsor
- Monument Therapeutics Limited
- Sponsor type
- Biotech company
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
- Locations
- United States
- Age range
- From 17 Years to 30 Years
- Official registry ID
- NCT07226895
- Official title
Show the full official title
A Study to Explore Changes in Cognitive, Clinical, Biological and Digital Measures Following 8 Weeks of Twice-daily Dosing of MT1988 and to Evaluate Safety & Tolerability of MT1988, in Participants at Clinical High Risk (CHR) for Psychosis
Recruitment & locations
RecruitingIrvine · Los Angeles · San Francisco
10 more locations
- New Haven
- Boston
- St Louis
- Glen Oaks
- New York
- Chapel Hill
- Columbus
- Eugene
- Philadelphia
- Pittsburgh
A listed location does not confirm current availability.
Questions about this study
Who is behind this study?
The study sponsor is Monument Therapeutics Limited.
Does this study involve medication?
Yes. The study involves medication, including MT1988 Low Dose, MT1988 High Dose and Placebo.
Who can participate?
Listed age limits: 17 years to 30 years.
Is this study still recruiting?
The registry lists this study as recruiting.
